Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
7/19/2024
Recent Executive Moves
7/19/2024
Experts Predict Novo Victory in Grueling Chinese Patent Case (MedWatcj...
7/18/2024
NMPA Suspends Import, Sales and Use of Daiwoong's Cefodizime Sodium fo...
7/18/2024
India's Pharma Contract Manufacturing Sector Set to Double in Three Ye...
7/18/2024
Marinus's Ganaxolone Approved in China as First Treatment for Seizures...
7/18/2024
Merck Unveils GMP-Compliant Cell Culture Media Manufacturing Line in C...
7/18/2024
China Sets Up National Working Group to Standardize Healthcare Securit...
7/17/2024
CDE Solicits Comments on Draft Implementation Suggestions and Chinese ...
7/16/2024
Who Will Acquire Legend Bio for 13B to 15B USD? Could It Be J&J? (Drug...
7/15/2024
China Biopharma Tracker – H1/2024 (PharmaNJ)
7/15/2024
China's Once-booming Online Healthcare Sector Sees Its Vital Signs Sin...
7/15/2024
GenScript's US Unit Legend Biotech Reportedly Receives Takeover Approa...
7/12/2024
AFT in China Distribution Deal with Hainan Haiyao for Skin Infection C...
7/12/2024
CDE Solicits Public Comments on ICH M14 and Its Chinese Translation
7/12/2024
Recent Executive Moves
7/11/2024
Eisai's Alzheimer's Drug LEQEMBI (Lecanemab) Approved in Hong Kong
7/11/2024
Biopharma Partnership Interest with China Remains High: LEK Survey
7/10/2024
House Speaker Mike Johnson Pledges Vote for BIOSECURE as China-targeti...
7/10/2024
China to DeepenHealthcare Reform in 2024
7/9/2024
Keymed Strikes Global Licensing Deal with Belenos
7/9/2024
SciClone Pharma Completes Privatization
7/8/2024
NMPA Vice Commissioner Meets Senior Dutch Healthcare Officials.
7/8/2024
China Expands Infectious Disease Direct Reporting System
7/5/2024
Recent Executive Moves
7/2/2024
Eisai and Biogen Launched Alzheimer's Drug LEQEMBI (Lecanemab) in Chin...
7/2/2024
BIOSECURE Act Impacts U.S. Biopharma Industry's Trust in Chinese Partn...
7/2/2024
Tracon's China-Approved Injectable Immune Checkpoint Inhibitor Faces S...
7/2/2024
HanAll and HBM Resubmits BLA for Myasthenia Gravis Treatment in China
6/28/2024
NHSA Issues the Working Plan and the Application Guide for Adjustment ...
6/28/2024
Recent Official and Executive Moves
Page:
23
/
354
Total number of articles:
10618
:
[First]
[<<]
[21]
[22]
[23]
[24]
[25]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit